Ftse Mib
33.311,37
1,23%
DAX
18.131,97
0,32%
S&P 500
5.482,87
0,18%
NASDAQ
17.860,48
0,02%
Bitcoin
64.664,48
-2,73%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Fibrocell Science Inc (FCSC) Fibrocell Science Inc (FCSC) Notizie

FCSC

Fibrocell Science (FCSC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FCSC
DataOraFonteTitoloSimboloCompagnia
07/01/202016:30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FCSCFibrocell Science Inc
18/12/201912:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FCSCFibrocell Science Inc
17/12/201923:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
13/12/201922:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FCSCFibrocell Science Inc
13/12/201922:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FCSCFibrocell Science Inc
13/12/201915:41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FCSCFibrocell Science Inc
13/12/201915:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
22/11/201912:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FCSCFibrocell Science Inc
14/11/201922:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FCSCFibrocell Science Inc
28/10/201921:04Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FCSCFibrocell Science Inc
26/10/201900:00PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Fibrocell Science, Inc.NASDAQ:FCSCFibrocell Science Inc
11/10/201922:52Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:FCSCFibrocell Science Inc
25/09/201922:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FCSCFibrocell Science Inc
17/09/201922:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FCSCFibrocell Science Inc
13/09/201900:35PR Newswire (US)Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
12/09/201923:40GlobeNewswire Inc.Castle Creek Pharmaceutical Holdings to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
29/08/201922:53Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FCSCFibrocell Science Inc
14/08/201922:45GlobeNewswire Inc.Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
30/05/201914:00GlobeNewswire Inc.Fibrocell to Present at BIO International Convention 2019NASDAQ:FCSCFibrocell Science Inc
29/05/201914:00GlobeNewswire Inc.Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEBNASDAQ:FCSCFibrocell Science Inc
15/05/201913:30GlobeNewswire Inc.Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
09/05/201914:00GlobeNewswire Inc.Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and ...NASDAQ:FCSCFibrocell Science Inc
29/04/201922:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FCSCFibrocell Science Inc
15/04/201912:30GlobeNewswire Inc.Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene TherapyNASDAQ:FCSCFibrocell Science Inc
03/04/201914:00GlobeNewswire Inc.Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate DirectorsNASDAQ:FCSCFibrocell Science Inc
27/03/201921:40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FCSCFibrocell Science Inc
27/03/201912:30GlobeNewswire Inc.Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-00...NASDAQ:FCSCFibrocell Science Inc
20/03/201913:00GlobeNewswire Inc.Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019NASDAQ:FCSCFibrocell Science Inc
14/02/201920:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FCSCFibrocell Science Inc
06/02/201914:00GlobeNewswire Inc.Fibrocell to Present at 21st Annual BIO CEO & Investor ConferenceNASDAQ:FCSCFibrocell Science Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FCSC

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
MONC
Moncler
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
A2A
A2A
BIT
SRG
Snam
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network